Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
70.13
-3.47 (-4.71%)
At close: Apr 28, 2026, 4:00 PM EDT
70.49
+0.36 (0.52%)
After-hours: Apr 28, 2026, 4:21 PM EDT
Arrowhead Pharmaceuticals Employees
Arrowhead Pharmaceuticals had 711 employees as of September 30, 2025. The number of employees increased by 102 or 16.75% compared to the previous year.
Employees
711
Change (1Y)
102
Growth (1Y)
16.75%
Revenue / Employee
$1,534,432
Profits / Employee
$284,480
Market Cap
9.82B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,100 |
| Jazz Pharmaceuticals | 2,890 |
| Ionis Pharmaceuticals | 1,402 |
| Exelixis | 1,077 |
| Axsome Therapeutics | 925 |
| Madrigal Pharmaceuticals | 915 |
| Vaxcyte | 507 |
ARWR News
- 4 days ago - Arrowhead Pharmaceuticals Receives Positive CHMP Opinion Recommending Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) in Europe - Business Wire
- 7 days ago - This Pharma Stock Is Up 460% Over the Past Year. What Could Be Key to Future Gains. - Barrons
- 8 days ago - Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Second Quarter Results - Business Wire
- 4 weeks ago - Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology's 75th Annual Scientific Session and Expo - Business Wire
- 7 weeks ago - Arrowhead Pharmaceuticals Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Arrowhead Pharmaceuticals Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Arrowhead Pharmaceuticals to Participate in Upcoming March 2026 Events - Business Wire
- 2 months ago - Arrowhead Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts